Extending Tamoxifen Saves Lives, Reduces Breast Cancer Recurrences, Study Finds

In a study that many breast cancer experts say may change practice, researchers have reported that extending the use of the drug tamoxifen to 10 years -- rather than the currently recommended five years -- could save lives by thwarting cancer's return. Breast cancer can recur even years after treatment. For the three quarters of breast cancers that are estrogen receptor (ER) positive, tamoxifen and other hormone therapy drugs have lowered the risk of cancer coming back. Long awaited data on...Full Story
Commenting on this article is closed.